All Stories

  1. One Enzyme, Many Faces: The Expanding Role of DPP3 in Cardiovascular and Critical Care
  2. Prognostic Impact of Obesity, Cardiometabolic Risk Factors, and Vascular Function Markers on Outcomes in Ischemic Cardiomyopathy
  3. The Role of miRNAs in Chemotherapy-Induced Cardiotoxicity
  4. Artificial intelligence-enabled electrocardiographic ‘sex discrepancy’ as a predictor of atrial fibrillation recurrence: contextualising the findings of Park et al
  5. Trends in Utilization of Guideline-Directed Cardiorenal Protective Therapies for Chronic Kidney Disease in Patients with Cardiovascular Morbidity: Real World Data from Two Cross-Sectional Snapshots (HECMOS I and II)
  6. The Role of NLRP3 Inflammasome in Type 2 Diabetes Mellitus and Its Macrovascular Complications
  7. Lipoprotein (a) in the Development and Progression of Diabetic Retinopathy: A Systematic Review and Meta-Analysis
  8. Real-World Efficacy and Safety of the Subcutaneous Implantable Cardioverter Defibrillator: Insights from the GASP Registry
  9. Hybrid Pulmonary Rehabilitation Improves Cardiorespiratory Exercise Fitness in Formerly Hospitalised Long COVID Patients
  10. Endothelial Function and Matrix Metalloproteinase 9 (MMP9) in Women with Polycystic Ovary Syndrome (PCOS)
  11. Mitochondrial Dysfunction in the Development and Progression of Cardiometabolic Diseases: A Narrative Review
  12. Endothelial Function and Pro-Inflammatory Cytokines as Prognostic Markers in Acute Coronary Syndromes
  13. A Tale of Two Diseases: Decoding Aortic Stenosis and Cardiac Amyloidosis
  14. Gut Microbiota in Heart Failure—The Role of Inflammation
  15. Baseline right ventricular-to-pulmonary artery coupling and outcomes after transcatheter aortic valve replacement: a systematic review and meta-analysis
  16. The Impact of the COVID-19 Pandemic on Medical Training at the Greek National Health Service: A Cross-Sectional Study
  17. Linking Cardiovascular Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Role of Cardiometabolic Drugs in MASLD Treatment
  18. Unraveling Metabolic Dysfunction-Associated Steatotic Liver Disease Through the Use of Omics Technologies
  19. Septic Cardiomyopathy: Difficult Definition, Challenging Diagnosis, Unclear Treatment
  20. FGF21 Analogues in Patients With Metabolic Diseases: Systematic Review and Meta‐Analysis of Randomised Controlled Trials
  21. Unraveling MASLD Through the Use of Omics Technologies
  22. The Effect of Cardiometabolic Drugs on Non-Alcoholic Fatty Liver Disease (NAFLD), Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD), and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
  23. Endothelial Glycocalyx Damage and Arterial Thickness in Patients with Retinal Vein Occlusion (RVO)
  24. MicroRNAs as Prognostic Biomarkers for Atrial Fibrillation Recurrence After Catheter Ablation: Current Evidence and Future Directions
  25. Cancer Therapy-Related Cardiac Dysfunction: A Review of Current Trends in Epidemiology, Diagnosis, and Treatment
  26. Navigating Heart–Lung Interactions in Mechanical Ventilation: Pathophysiology, Diagnosis, and Advanced Management Strategies in Acute Respiratory Distress Syndrome and Beyond
  27. Tailored Therapies for Cardiogenic Shock in Hypertrophic Cardiomyopathy: Navigating Emerging Strategies
  28. Dulaglutide and Dapagliflozin Combination Concurrently Improves the Endothelial Glycocalyx and Vascular and Myocardial Function in Patients with T2DM and Albuminuria vs. DPP-4i
  29. Response to “Letter to Editor From Ishaq MU et al: ‘Semaglutide Concurrently Improves Vascular and Liver Indices in Patients With Type 2 Diabetes and Fatty Liver Disease’”
  30. Wearable Activity Trackers and Physical Activity Levels Among Members of the Athens Medical Association in Greece
  31. Multifaceted Impact of SGLT2 Inhibitors in Heart Failure Patients: Exploring Diverse Mechanisms of Action
  32. The Cardiometabolic Risk in Women with Polycystic Ovarian Syndrome (PCOS): From Pathophysiology to Diagnosis and Treatment
  33. Influenza Vaccination Practices and Perceptions Among Young Athletes: A Cross-Sectional Study in Greece
  34. Exercise Intolerance Is Associated with Cardiovascular Dysfunction in Long COVID-19 Syndrome
  35. Bridge to Life: Current Landscape of Temporary Mechanical Circulatory Support in Heart-Failure-Related Cardiogenic Shock
  36. The Association of Systemic Endothelial Dysfunction With Diffuse Diabetic Macular Edema
  37. The Impact of the COVID-19 Pandemic on Elite Swimmers and Water Polo Players: Lessons for the Future
  38. Impairment in Right Ventricular-Pulmonary Arterial Coupling in Overweight and Obesity
  39. Coronary Plaque Erosion: Epidemiology, Diagnosis, and Treatment
  40. Young and older patients with acute myocardial infarction: differences in risk factors and angiographic characteristics
  41. MicroRNAs in Atrial Fibrillation: Mechanisms, Vascular Implications, and Therapeutic Potential
  42. Unveiling the Role of Endothelial Dysfunction: A Possible Key to Enhancing Catheter Ablation Success in Atrial Fibrillation
  43. Silent Myocardial Ischemia: From Pathophysiology to Diagnosis and Treatment
  44. The Role of Ranolazine in Heart Failure-Current Concepts
  45. Diabetes Mellitus in Acute Coronary Syndrome
  46. New-Onset Atrial Fibrillation in the Critically Ill COVID-19 Patients Hospitalized in the Intensive Care Unit
  47. Impact of drinking water hardness on carotid atherosclerosis and arterial stiffness: Insights from the “Corinthia” study
  48. Novel Biomarkers and Their Role in the Diagnosis and Prognosis of Acute Coronary Syndrome
  49. Non-Alcoholic Fatty Liver Disease and Echocardiographic Parameters of Left Ventricular Diastolic Function: A Systematic Review and Meta-Analysis
  50. Attitudes and Practices Related to COVID-19 Vaccination with the Second Booster Dose among Members of Athens Medical Association: Results from a Cross-Sectional Study
  51. Novel Approaches to the Management of Diabetes Mellitus in Patients with Coronary Artery Disease
  52. Inflammasomes in Atherosclerosis—From Pathophysiology to Treatment
  53. Metabolic Syndrome and Atrial Fibrillation: Different Entities or Combined Disorders
  54. Exercise Effects on Left Ventricular Remodeling in Patients with Cardiometabolic Risk Factors
  55. Diffuse LAD and LV Thrombus as Possible Manifestation of Protein-S Deficiency in a Young Patient
  56. Novel Anti-Inflammatory Therapies in Coronary Artery Disease and Acute Coronary Syndromes
  57. The Role of Right Ventriculo–Arterial Coupling in Symptoms Presentation of Patients with Hypertrophic Cardiomyopathy
  58. Correlation of Clinical Outcomes with the Prominent Indication of Transcatheter Paravalvular Leak Closure: A Multicenter Experience
  59. Exercise Effects on Left Ventricular Remodeling in Patients With Cardiometabolic Risk Factors
  60. The Role of Right Ventriculo-Arterial Coupling in Symptoms Presentation of Patients With Hypertrophic Cardiomyopathy
  61. Midterm Outcomes in Patients With Aortic Stenosis Treated With Contemporary Balloon‐Expandable and Self‐Expanding Valves: Does Valve Size Have an Impact on Outcome?
  62. The Role of Macrophages in Atherosclerosis: Pathophysiologic Mechanisms and Treatment Considerations
  63. Lipoprotein(a) and calcific aortic valve disease initiation and progression: a systematic review and meta-analysis
  64. The Role of Rehabilitation in Arterial Function Properties of Convalescent COVID-19 Patients
  65. Impact of Evolution of Self-Expandable Aortic Valve Design: Peri-Operative and Short-Term Outcomes
  66. Molecular Mechanisms and Therapeutic Implications of Endothelial Dysfunction in Patients with Heart Failure
  67. Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment
  68. Lipoprotein (a) levels and Abdominal Aortic Aneurysm. A Systematic Review and Meta-analysis
  69. The Anti-Inflammatory Effect of Novel Antidiabetic Agents
  70. Interleukin-1 in Coronary Artery Disease
  71. Vaccination Against SARS-CoV-2 Protects from COVID-19-induced Endothelial Dysfunction
  72. Evaluation of the Perceptions, Attitudes and Practices among Greek Non-Professional Athletes Visiting a Public Hospital during March 2022, towards COVID-19 Vaccination and Its Consequences on Sports Training and Sports Activity
  73. The effect of stress management in patients post-acute myocardial infarction
  74. Impaired left ventricular deformation and ventricular-arterial coupling in post-COVID-19: association with autonomic dysregulation
  75. COVID-19, Endothelium and the Cardiometabolic Patient: A Possible Role for Capillary Leak Syndrome
  76. Granulocyte Colony-Stimulating Factor Ameliorates Endothelial Activation and Thrombotic Diathesis Biomarkers in a Murine Model of Hind Limb Ischemia
  77. Percutaneous Treatment Approaches in Atrial Fibrillation: Current Landscape and Future Perspectives
  78. Pericoronary fat attenuation index—a new imaging biomarker and its diagnostic and prognostic utility: a systematic review and meta-analysis
  79. Association of Growth Differentiation Factor 15 with Arterial Stiffness and Endothelial Function in Subpopulations of Patients with Coronary Artery Disease: A Proof-of-Concept Study
  80. Non-Invasive Modalities in the Assessment of Vulnerable Coronary Atherosclerotic Plaques
  81. The Role of Endothelial Related Circulating Biomarkers in COVID-19. A Systematic Review and Meta-analysis
  82. The Role of Cell-derived Microparticles in Cardiovascular Diseases: Current Concepts
  83. Increased Influenza Vaccination Coverage among Members of the Athens Medical Association Amidst COVID-19 Pandemic
  84. Expression of Tissue microRNAs in Ascending Aortic Aneurysms and Dissections
  85. Evaluation of Knowledge, Attitudes and Practices Related to Self-Testing Procedure against COVID-19 among Greek Students: A Pilot Study
  86. Factors Associated with Platelet Activation-Recent Pharmaceutical Approaches
  87. The association of diabetes mellitus with carotid atherosclerosis and arterial stiffness in the Corinthia study
  88. The Association of Physical Activity with Arterial Stiffness and Inflammation: Insight from the “Corinthia” Study
  89. A case report of left ventricular thrombus formation following aggressive decongestion treatment
  90. Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand?
  91. Association of arterial stiffness with functional parameters in patients with systolic heart failure: Data from the Corinthia study
  92. Atrial Fibrillation: Pathogenesis, Predisposing Factors, and Genetics
  93. Inflammation in Coronary Microvascular Dysfunction
  94. MicroRNAs as Biomarkers in Hypertrophic Cardiomyopathy: Current State of the Art
  95. Inflammatory Mediators of Platelet Activation: Focus on Atherosclerosis and COVID-19
  96. Sex Differences in Clinical Outcomes of Patients with Stable Coronary Artery Disease after Percutaneous Coronary Intervention
  97. MicroRNAs in the Management of Heart Failure
  98. Risk factors profile of young and older patients with myocardial infarction
  99. Inflammatory Mechanisms Contributing to Endothelial Dysfunction
  100. Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives
  101. The Hellenic Journal of Cardiology: a 64-year voyage of discovery from the cradle of European civilization to the world
  102. Regulation of Long Non-Coding RNAs by Statins in Atherosclerosis
  103. The Effect of DPP-4i on Endothelial Function and Arterial Stiffness in Patients with Type 2 Diabetes: A Systematic Review of Randomized Placebo-controlled Trials
  104. Novel Antidiabetic Agents: Cardiovascular and Safety Outcomes
  105. Association of Soluble Suppression of Tumorigenesis-2 (ST2) with Endothelial Function in Patients with Ischemic Heart Failure
  106. Pro-inflammatory Cytokines in Acute Coronary Syndromes
  107. Arterial stiffness and microvascular disease in type 2 diabetes
  108. “The role of intracoronary administration of stem cells on myocardial reperfusion injury”
  109. Hospital attendance and admission trends for cardiac diseases during the COVID-19 outbreak and lockdown in Greece
  110. High-Intensity Endurance and Strength Training in Water Polo Olympic Team Players: Impact on Arterial Wall Properties
  111. Antithrombotic Treatment in Diabetes Mellitus: A Review of the Literature about Antiplatelet and Anticoagulation Strategies Used for Diabetic Patients in Primary and Secondary Prevention
  112. Antithrombotic Therapy in Carotid Artery Disease
  113. Current Antithrombotic Therapy: Beyond Coronary Artery Disease
  114. Proposed algorithm for return to sports in competitive athletes who have suffered COVID-19
  115. Development of a risk score for early saphenous vein graft failure: An individual patient data meta-analysis
  116. A reappraisal of the role of transthoracic ultrasound in the era of COVID-19. Patient evaluation through new windows
  117. Relationship between whole grain consumption and arterial stiffness. Results of the Corinthia cross-sectional study
  118. Acute Coronary Syndrome with Non-ruptured Plaques (NONRUPLA): Novel Ideas and Perspectives
  119. Cardiovascular disease and socioeconomic status
  120. Alirocumab and evolocumab: an indirect comparison of cardiovascular benefits
  121. Endothelial dysfunction and impaired arterial wall properties in patients with retinal vein occlusion
  122. MicroRNAs in Cardiovascular Disease
  123. The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design
  124. Coronary Artery Disease and Endothelial Dysfunction: Novel Diagnostic and Therapeutic Approaches
  125. Mir-335-5p as a Potential Regulator of LRP1 Expression in Abdominal Aortic Aneurysm
  126. Acute exposure to diesel affects inflammation and vascular function
  127. Aortic regurgitation in competitive athletes: The role of multimodality imaging for clinical decision-making
  128. Diagnostic performance of electrocardiographic criteria in echocardiographic diagnosis of different patterns of left ventricular hypertrophy
  129. The aetiology of death for marathon runner Phidippides?
  130. Reply: Possible Effect of Alcohol Consumption on Aortic Dilatation by Inducing the Renin–Angiotensin–Aldosterone System
  131. Aortic stiffening is associated with increased left ventricular mass in women but not in men
  132. Breakfast association with arterial stiffness and carotid atherosclerotic burden. Insights from the ‘Corinthia’ study
  133. Galectin-3 and Arterial Stiffness in Patients with Heart Failure: A Pilot Study
  134. The influence of resting heart rate on pulse wave velocity measurement is mediated by blood pressure and depends on aortic stiffness levels: insights from the Corinthia study
  135. Pseudoexfoliative Glaucoma, Endothelial Dysfunction, and Arterial Stiffness
  136. Alcohol Consumption and Aortic Root Dilatation: Insights from the Corinthia Study
  137. Arterial stiffness and subclinical aortic damage of reclassified subjects as stage 1 hypertension according to the new 2017 ACC/AHA blood pressure guidelines
  138. Atrial Fibrillation: Biomarkers Determining Prognosis
  139. Biomarkers Determining Prognosis of Atrial Fibrillation Ablation
  140. Biomarkers in Atrial Fibrillation and Heart Failure
  141. MicroRNAs in Atrial Fibrillation
  142. Galectin-3
  143. Cardiovascular effects of electronic cigarettes: A systematic review and meta-analysis
  144. The effect of diet, lifestyle and psychological factors in the prognosis of ischemic heart failure
  145. Hyponatremia in patients with atrial fibrillation and heart failure: The difficult triangle
  146. Vitamin D: A cardiovascular risk biomarker or a treatment target?
  147. Cancer Therapeutics-Related Cardiovascular Complications. Mechanisms, Diagnosis and Treatment
  148. Heart failure a cluster of comorbidities or a unique entity?
  149. Associations between Adiponectin Gene Variability, Proinflammatory and Angiogenetic Markers: Implications for Microvascular Disease Development in Type 2 Diabetes Mellitus?
  150. The impact of sedentary behavior patterns on carotid atherosclerotic burden: Implications from the Corinthia epidemiological study
  151. The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives
  152. Effects of Newer Antidiabetic Drugs on Endothelial Function and Arterial Stiffness: A Systematic Review and Meta-Analysis
  153. The association among biomarkers of renal and heart function in patients with heart failure: the role of NGAL
  154. Coronary Microcirculation and the No-reflow Phenomenon
  155. Myocardial performance versus exercise tolerance. What matters the most in patients with heart failure?
  156. The Impact of Omega 3 Fatty Acids in Atherosclerosis and Arterial Stiffness: An Overview of their Actions
  157. Polymorphism Gln27Glu of β2 Adrenergic Receptors in Patients with Ischaemic Cardiomyopath
  158. Inflammation: A pathogenetic mechanism or a mediator, linking risk factors and cardiovascular disease?
  159. Non-natriuretic peptide biomarkers in heart failure with preserved and reduced ejection fraction
  160. Effects of omega-3 polyunsaturated fatty acids on fibrosis, endothelial function and myocardial performance, in ischemic heart failure patients
  161. Circulating microparticles: Simply a research tool or a candidate clinical meaningful biomarker?
  162. Local Low Shear Stress and Endothelial Dysfunction in Patients With Nonobstructive Coronary Atherosclerosis
  163. Impact of “high” implantation on functionality of self-expandable bioprosthesis during the short- and long-term outcome of patients who undergo transcatheter aortic valve implantation: Is high implantation beneficial?
  164. Anti-inflammatory agents in peripheral arterial disease
  165. Coronary versus carotid artery plaques. Similarities and differences regarding biomarkers morphology and prognosis
  166. Editorial overview: Cardiovascular and renal: Novel therapies in peripheral artery disease
  167. Peripheral artery disease: a micro-RNA-related condition?
  168. Predictors of switching from nonsteroidal anti-inflammatory drugs to corticosteroids in patients with acute pericarditis and impact on clinical outcome
  169. Interrelationship between diabetes mellitus and heart failure: the role of peroxisome proliferator-activated receptors in left ventricle performance
  170. Echocardiography for the management of patients with biventricular pacing: Possible roles in cardiac resynchronization therapy implementation
  171. Statins and Contrast-Induced Nephropathy: A Systematic Review and Meta-Analysis
  172. Statins in Aortic Disease
  173. Prognostic significance of arterial stiffness and osteoprotegerin in patients with stable coronary artery disease
  174. 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomographic Imaging Detects Aortic Wall Inflammation in Patients With Repaired Coarctation of Aorta
  175. Flow-Mediated Dilation of Brachial Artery as a Screening Tool for Anthracycline-Induced Cardiotoxicity
  176. Statins and inflammation in cardiovascular disease
  177. Statins and left ventricular function
  178. Statins in Stable Angina Pectoris
  179. Statins in Aortic Stenosis
  180. Long-term endothelial dysfunction after trans-radial catheterization: A meta-analytic approach
  181. Western Dietary Pattern Is Associated With Severe Coronary Artery Disease
  182. Redox State in Atrial Fibrillation Pathogenesis and Relevant Therapeutic Approaches
  183. Macrovascular function indices for the prediction of diabetic retinopathy development in patients with type 2 diabetes
  184. Antiplatelet and Anticoagulation Therapy in Structural Heart Disease Interventions Beyond TAVI
  185. Genetics in the Clinical Decision of Antiplatelet Treatment
  186. Beneficial Effects of Sildenafil on Tissue Perfusion and Inflammation in a Murine Model of Limb Ischemia and Atherosclerosis
  187. Impact of balloon aortic valvuloplasty on transcatheter aortic valve implantation with self-expandable valve
  188. Genotyping, Platelet Activation, and Cardiovascular Outcome in Patients after Percutaneous Coronary Intervention: Two Pieces of the Puzzle of Clopidogrel Resistance
  189. Prognostic implications of epicardial fat volume quantification in acute pericarditis
  190. Established and novel treatment options in acute myocarditis, with or without heart failure
  191. Correlation of CoreValve implantation ‘true cover index’ with short and mid-term aortic regurgitation: A novel index
  192. The impact of T786C and G894T polymorphisms of eNOS on vascular endothelial growth factor serum levels in type 2 diabetes patients
  193. Effects of transradial coronary catheterization on systemic and local vascular endothelial function and inflammatory process
  194. Usefulness of C-Reactive Protein as a Predictor of Contrast-Induced Nephropathy After Percutaneous Coronary Interventions in Patients With Acute Myocardial Infarction and Presentation of a New Risk Score (Athens CIN Score)
  195. Novel risk factors’ hunting. Lessons from the study of older olds
  196. The effect of in-hospital acquired thrombocytopenia on the outcome of patients with acute coronary syndromes: A systematic review and meta-analysis
  197. The prognostic role of C-reactive protein after myocardial infarction in patients with normal or mildly impaired left ventricle systolic function
  198. Dual or Single Antiplatelet Therapy After Transcatheter Aortic Valve Implantation? A Systematic Review and Meta-Analysis
  199. Targeting percutaneous cardiovascular interventions at all who will benefit the most: The reality of the Eastern European countries
  200. The impact of dietary flavonoid supplementation on smoking-induced inflammatory process and fibrinolytic impairment
  201. Duration of Dual Antiplatelet Therapy after Coronary Stenting
  202. Acute effects of different types of aerobic exercise on endothelial function and arterial stiffness
  203. Characterization of vascular phenotype in patients with coronary artery ectasia: The role of endothelial dysfunction
  204. The Interaction Between Gender and Diabetes Mellitus in the Coronary Heart Disease Risk
  205. Antiplatelet Therapy in Acute Coronary Syndromes. Evidence Based Medicine
  206. Incessant pericarditis following dual-chamber cardioverter defibrillation device implantation
  207. Environment and cardiovascular disease: rationale of the Corinthia study
  208. Do we really need novel echocardiographic modalities to confirm the superiority of the intact His-Purkinje conduction system over pacing modes?
  209. Impact of C34T P2Y12 ADP receptor polymorphism and smoking status on cardiovascular outcome in coronary artery disease patients receiving clopidogrel
  210. Impairment of arterial elastic properties and elevated circulating levels of transforming growth factor-beta in subjects with repaired coarctation of aorta
  211. Basic Mechanisms in Atherosclerosis: The Role of Calcium
  212. Inflammatory cytokines in atherosclerosis: current therapeutic approaches
  213. The Acute Impact of Different Types of Aerobic Exercise on Arterial Wave Reflections and Inflammation
  214. Atherogenesis and hyperlipidemia a not straightforward association: We really need a novel biomarker?
  215. Different Prognostic Significance of Cardiac Troponin at Presentation and Peak Cardiac Troponin in Patients with Non-ST Segment Elevation Myocardial Infarction
  216. Impact of Laparoscopic Sleeve Gastrectomy on Weight Loss and Associated Comorbidities in Adolescents and Young Adults
  217. Real-time three-dimensional echocardiography: never before clinical efficacy looked so picturesque
  218. Clopidogrel response variability is associated with endothelial dysfunction in coronary artery disease patients receiving dual antiplatelet therapy
  219. Arterial Wall Elastic Properties and Endothelial Dysfunction in the Diabetic Foot Syndrome in Patients With Type 2 Diabetes
  220. The role of microRNAs in coronary artery disease: From pathophysiology to diagnosis and treatment
  221. Vascular function and ocular involvement in sarcoidosis
  222. Genetic testing and antiplatelet treatment: Still way to go?
  223. Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients
  224. Flow-mediated dilation: Is it just a research tool or a useful biomarker for cardiovascular prognosis
  225. An unusual case of a three coronary artery spasm
  226. Role of Endothelial Dysfunction and Arterial Stiffness in the Development of Diabetic Retinopathy: Figure 1
  227. Reply: Long term impact of CPAP on myocardial function in OSA. Always measurable cardiac index?
  228. Endothelial dysfunction in conduit arteries and in microcirculation. Novel therapeutic approaches
  229. Impact of C34T P2Y12 genotype on endothelial function and arterial stiffness in patients after percutaneous coronary intervention receiving clopidogrel
  230. Impact of folic acid administration in homocysteine levels, inflammation and in atherosclerotic plaque area in apoE deficient mice
  231. Oxidative Stress and Early Atherosclerosis: Novel Antioxidant Treatment
  232. High platelet reactivity is associated with vascular function in patients after percutaneous coronary intervention receiving clopidogrel
  233. Segmental myocardial hypokinesis and hypertrophy as initial echocardiographic presentation of myocarditis
  234. Combined effects of smoking and interleukin-6 and C-reactive protein genetic variants on endothelial function, inflammation, thrombosis and incidence of coronary artery disease
  235. Vascular effects of circulating CD4-T cells in patients with unstable angina
  236. Pro-Inflammatory Interleukin Genotypes Potentiate Early and Advanced Atherosclerosis Differently
  237. Impact of continuous positive airway pressure treatment on myocardial performance in patients with obstructive sleep apnea. A conventional and tissue Doppler echocardiographic study
  238. Cystatin-C serum levels and vascular function in heart failure
  239. Divergent effects of folic acid administration on inflammatory status and cholesterol levels in apoE deficient mice
  240. The Natural History of Multifocal Atrial Rhythms in Elderly Outpatients: Insights from the “Ikaria Study”
  241. The impact of AMPD1 gene polymorphism on vascular function and inflammation in patients with coronary artery disease
  242. Novel biomarkers in heart failure: usefulness in clinical practice
  243. Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome
  244. Statins in heart failure—With preserved and reduced ejection fraction. An update
  245. Vitamin D serum levels are associated with cardiovascular outcome in coronary artery disease
  246. Favorable Effects of Concord Grape Juice on Endothelial Function and Arterial Stiffness in Healthy Smokers
  247. Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease
  248. The impact of CYP2C19 genotype on cardiovascular events and platelet reactivity in patients with coronary artery disease receiving clopidogrel
  249. Long-Term Fish Intake Preserves Kidney Function in Elderly Individuals: The Ikaria Study
  250. MicroRNAs: Novel Diagnostic and Prognostic Biomarkers in Atherosclerosis
  251. Novel Biomarkers Assessing Endothelial Dysfunction: Role of microRNAs
  252. MicroRNAs: Biomarkers for Cardiovascular Disease in Patients with Diabetes Mellitus
  253. Diagnostic and Therapeutic Potentials of microRNAs in Heart Failure
  254. MicroRNAs in the Diagnosis and Treatment of Unstable Angina
  255. MicroRNAs in Cardiovascular Therapeutics
  256. Effects of omega-3 fatty acids on endothelial function, arterial wall properties, inflammatory and fibrinolytic status in smokers: A cross over study
  257. Flavonoids in Atherosclerosis: An Overview of Their Mechanisms of Action
  258. Dose-dependent effects of short term atorvastatin treatment on arterial wall properties and on indices of left ventricular remodeling in ischemic heart failure
  259. Consumption of a boiled Greek type of coffee is associated with improved endothelial function: The Ikaria Study
  260. Genetic Predisposition to Left Ventricular Hypertrophy and the Potential Involvement of Cystatin-C in Untreated Hypertension
  261. Aortic elastic properties and cognitive function in elderly individuals: The Ikaria Study
  262. Low Total Testosterone Levels are Associated With the Metabolic Syndrome in Elderly Men: The Role of Body Weight, Lipids, Insulin Resistance, and Inflammation; The Ikaria Study
  263. Aortic artery distensibility shows inverse correlation with heart rate variability in elderly non-hypertensive, cardiovascular disease-free individuals: the Ikaria Study
  264. Comparable effects of pioglitazone and perindopril on circulating endothelial progenitor cells, inflammatory process and oxidative stress in patients with diabetes mellitus
  265. Adiponectin and Cardiovascular Disease: Mechanisms and New Therapeutic Approaches
  266. Genetic polymorphism M235T of angiotensinogen: Effects on endothelial function and arterial stiffness in hypertensives
  267. Novel Biomarkers Assessing the Calcium Deposition in Coronary Artery Disease
  268. Asymmetric dimethylarginine (ADMA): Is really a biomarker for cardiovascular prognosis?
  269. Cross-sectional relationship of a Mediterranean type diet to diastolic heart function in chronic heart failure patients
  270. Anti-tumor necrosis factor alpha treatment with adalimumab improves significantly endothelial function and decreases inflammatory process in patients with chronic psoriasis
  271. Distinct role of electrocardiographic criteria in echocardiographic diagnosis of left ventricular hypertrophy according to age, in the general population
  272. Gender variation of exercise-induced anti-arrhythmic protection: the Ikaria Study
  273. Association of Sarcoidosis With Endothelial Function, Arterial Wall Properties, and Biomarkers of Inflammation
  274. The association between glaucoma, vascular function and inflammatory process